Skip to main content
Log in

Prevalence of subclinical hepatic encephalopathy in cirrhotics and relationship to plasma amino acid imbalance

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Neuropsychological status, as assessed by trailmaking test; plasma amino acids, and ammonia, were studied in 54 cirrhotics without clinical evidence of encephalopathy to determine the prevalence of subclinical mental dysfunction and its relationship to metabolic abnormalities. Control values for psychometric performance were established in 54 normal subjects matched for age, sex, educational level, and employment status. Of these subjects, 16 were also used as controls for fasting ammonia and plasma amino acids. Eighteen cirrhotics (33%) showed impaired performances of the psychometric test; free tryptophan and the ratio free tryptophan to neutral amino acids were increased in 37% and 62% of cases and correlated with the psychometric scores (r=0.45 andr=0.70, respectively). In eight cirrhotics with mild encephalopathy, psychometric and metabolic evaluations were repeated several times during the infusion of amino acid solutions rich in branched-chain amino acids. Again significant correlations were observed between the psychometric scores and plasma amino acids. We conclude that a considerable proportion of clinically normal cirrhotics have neuropsychological deficits. The severity of impairment may be related to the plasma amino acid imbalance, namely to an increased passage of tryptophan across the blood-brain barrier.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Conn HO: Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy. Am J Dig Dis 22:541–550, 1977

    Google Scholar 

  2. Lam KC, Tall AR, Goldstein GB, Mistilis SP: Role of a false neurotransmitter, octopamine, in the pathogenesis of hepatic and renal encephalopathy. Scand J Gastroenterol 8:465–472, 1973

    Google Scholar 

  3. Smith HH, Jr, Smith LS: WAIS functioning of cirrhotic and non-cirrhotic alcoholics. J Clin Psychol 33:309–313, 1977

    Google Scholar 

  4. Gilberstadt S, Gilberstadt H, Buegel B, Collier R, McClain CJ, Zieve L: Defective intellectual function in alcoholic cirrhotics and noncirrhotic alcoholics: Relationship to severity of liver disease. Gastroenterology 74:1037, 1978

    Google Scholar 

  5. Rehnstrom S, Simert G, Hansson JA, Johnson G, Vang J: Chronic hepatic encephalopathy. A psychometrical study. Scand J Gastroenterol 12:305–311, 1977

    Google Scholar 

  6. Rikkers L, Jenko P, Rudman D, Freides D: Subclinical hepatic encephalopathy: Detection, prevalence, and relationship to nitrogen metabolism. Gastroenterology 75:462–469, 1978

    Google Scholar 

  7. Zieve L: Hepatic encephalopathy: Summary of present knowledge with an elaboration on recent developments.In Progress in Liver Diseases, Vol VI, H Popper, F Schaffner (eds). New York, Grune & Stratton, 1979, pp 327–341

    Google Scholar 

  8. McDermott WW: The role of ammonia intoxication in hepatic coma. Bull NY Acad Med 34:352–365, 1958

    Google Scholar 

  9. Fischer JE, Baldessarini RJ: Pathogenesis and therapy of hepatic coma.In Progress in Liver Diseases, Vol V, H Popper, F Schaffner (eds). New York, Grune & Stratton, 1976, pp 363–397

    Google Scholar 

  10. Picchiotti R, Bandiera G, Capocaccia L, Attili AF, Donini G, Barnabei A, Panchieri P, Mosticoni R: Portosystemic encephalopathy in cirrhotic patients following portocaval shunt. Quantitative evaluation of neuropsychiatric damage. Ital J Gastroenterol 11:15–20, 1979

    Google Scholar 

  11. Cangiano C, Calcaterra V, Cascino A, Rossi-Fanelli F, Capocaccia L: The role of the false neurotransmitters, octopamine and phenylethanolamine, in human hepatic encephalopathy. Rendic Gastroenterol 9:189–193, 1977

    Google Scholar 

  12. Dodsworth JM, James JH, Cummings MG, Fischer JE: Depletion of brain norepinephrine in acute hepatic coma. Surgery 75:811–820, 1974

    Google Scholar 

  13. Jequier E, Lovenberg W, Sjoersma A: Tryptophan hydroxilase inhibition: The mechanism by whichp-chlorophenylalanine depletes rat brain serotonin. Mol Pharmacol 3:274–299, 1967

    Google Scholar 

  14. Baldessarini RJ, Karobath M: Biochemical physiology of central synapsis. Annu Rev Physiol 35:273–304, 1973

    Google Scholar 

  15. James JH, Hodgman JM, Funovics JM, Yoshimura M, Fischer JE: Brain tryptophan, plasma free tryptophan, and distribution of plasma neutral amino acids. Metabolism 25:471–476, 1976

    Google Scholar 

  16. Cascino A, Cangiano C, Calcaterra V, Rossi-Fanelli F, Capocaccia L: Plasma amino acid imbalance in patients with liver disease. Am J Dig Dis 23:591–598, 1978

    Google Scholar 

  17. Marchesini G, Forlani G, Zoli M, Angiolini A, Scolari MP, Bianchi FB, Pisi E: Insulin and glucagon levels in liver cirhosis: Relationship with the plasma amino acid imbalance of chronic hepatic encephalopathy. Dig Dis Sci 24:594–601, 1979

    Google Scholar 

  18. Reitan RM: The relation of the trailmaking test to organic brain damage. J Consult Psychol 19:393–405, 1955

    Google Scholar 

  19. Davidson EA, Summerskill WHJ: Psychiatric aspects of liver disease. Postgrad Med J 32:487–502, 1956

    Google Scholar 

  20. Fischer JE, Funovics JM, Aguirre A, James JH, Keane JM, Wesdorp RIC, Yoshimura N, Westman T: The role of plasma amino acids in hepatic encephalopathy. Surgery 78:276–290, 1975

    Google Scholar 

  21. Marchesini G, Forlani G, Angiolini A, Zoli M, Scolari MP, Bianchi FB, Pisi E: Oral glucose in cirrhotics. Effects on plasma amino acid patterns and the role of insulin and glucagon. Diabetes Metab 5:135–139, 1979

    Google Scholar 

  22. Seligson D, Hirahara K: The measurement of ammonia in whole blood, erythrocytes and plasma. J Lab Clin Med 49:962–974, 1957

    Google Scholar 

  23. Zeegen R, Drinkwater JE, Dawson AM: Methods of measuring cerebral dysfunction in patients with liver disease. Br Med J 2:633–636, 1970

    Google Scholar 

  24. Cangiano C, Calcaterra V, Cascino A, Capocaccia L: Bound and free tryptophan plasma levels in hepatic encephalopathy. Rendic Gastroenterol 8:186–189, 1976

    Google Scholar 

  25. Ono J, Hutson DG, Dombro RS, Levi JU, Livingstone A, Zeppa R: Tryptophan and hepatic coma. Gastroenterology 74:196–200, 1978

    Google Scholar 

  26. Rosen HM, Yoshimura N, Hodgman JM, Fischer JE: Plasma amino acid patterns in hepatic encephalopathy of differing etiology. Gastroenterology 72:483–487, 1977

    Google Scholar 

  27. Marchesini G, Zoli M, Cecchini L, Dondi C, Bianchi FB, Pisi E: The number-connection test and plasma amino acid profile in the aseessment of subclinical or mild encephalopathy in liver cirrhosis. Proceedings of the 14th Meeting of the European Association for the Study of the Liver (EASL), Düsseldorf, West Germany, Graefelfing, Demeter, 1979, p 57

  28. James JH, Jeppson B, Ziparo V, Fischer JE: Hyperammonaemia, plasma amino acid imbalance, and blood-brain amino acid transport: A unified theory of portal-systemic encephalopathy. Lancet 2:772–775, 1979

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marchesini, G., Zoli, M., Dondi, C. et al. Prevalence of subclinical hepatic encephalopathy in cirrhotics and relationship to plasma amino acid imbalance. Digest Dis Sci 25, 763–768 (1980). https://doi.org/10.1007/BF01345296

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01345296

Keywords

Navigation